Brainstorm Cell Therapeutics Inc (NAS:BCLI)
$ 1.68 -0.12 (-6.67%) Market Cap: 8.93 Mil Enterprise Value: 7.06 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 33/100

Brainstorm Cell Therapeutics Inc (BCLI) Transcripts

  • 1